InvestSMART

Next Science Limited (ASX: NXS) - Announcements

DELISTED - Current share price for NXS : $0.145

ASX company news and announcements for Next Science Limited (NXS) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Next Science Limited (NXS) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Next Science Limited (NXS), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Next Science Limited (NXS)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Application for quotation of securities - NXS 11 Jul 2025 9:21AM $0.135 $0.145 risen by 7.41%
- Next Science to Sell Majority of Assets 1 Jul 2025 8:28AM $0.067 $0.145 risen by 116.42%
- 2025 AGM - Voting Results 9 May 2025 12:15PM $0.096 $0.145 risen by 51.04%
- 2025 AGM Presentation 9 May 2025 10:05AM $0.096 $0.145 risen by 51.04%
- AGM Chair & CEO Addresses 9 May 2025 10:05AM $0.096 $0.145 risen by 51.04%
- Derivative complaint dismissed 5 May 2025 8:44AM $0.091 $0.145 risen by 59.34%
- Notification of cessation of securities - NXS 2 May 2025 10:24AM $0.087 $0.145 risen by 66.67%
- Quarterly Activity Report & Appendix 4C - 31 March 24 Apr 2025 8:22AM $0.099 $0.145 risen by 46.46%
- Appendix 4G & 2025 Corporate Governance Statement 17 Apr 2025 5:02PM $0.099 $0.145 risen by 46.46%
- 2024 Annual Report 17 Apr 2025 4:52PM $0.099 $0.145 risen by 46.46%
- Notice of 1Q FY25 Result and Investor Webinar 11 Apr 2025 8:24AM $0.100 $0.145 risen by 45%
- 2025 AGM - Notice of Meeting 4 Apr 2025 4:58PM $0.100 $0.145 risen by 45%
- Notice of Change of Share Registry 14 Mar 2025 8:24AM $0.105 $0.145 risen by 38.10%
- 2025 Annual General Meeting - Notification of dates 11 Mar 2025 10:13AM $0.100 $0.145 risen by 45%
- Change in substantial holding from Tiga Trading Pty Ltd 3 Mar 2025 5:16PM $0.105 $0.145 risen by 38.10%
- Change in substantial holding from TEK 3 Mar 2025 5:15PM $0.105 $0.145 risen by 38.10%
- FY24 Annual Result Investor Presentation 28 Feb 2025 8:42AM $0.105 $0.145 risen by 38.10%
- Next Science reports FY24 Result 28 Feb 2025 8:41AM $0.105 $0.145 risen by 38.10%
- FY24 Appendix 4E and Financial Report 28 Feb 2025 8:35AM $0.105 $0.145 risen by 38.10%
- Next Science receives FDA Warning Letter 25 Feb 2025 9:27AM $0.120 $0.145 risen by 20.83%
- Notice of FY24 Result and Investor Webinar 7 Feb 2025 10:51AM $0.125 $0.145 risen by 16%
- Notification of cessation of securities - NXS 29 Jan 2025 9:49AM $0.120 $0.145 risen by 20.83%
- Appendix 4C & Quarterly Activity Report - 31 December 23 Jan 2025 8:20AM $0.145 $0.145 fallen by 0%
- Notice of 4Q FY24 Result and Investor Webinar 20 Jan 2025 9:14AM $0.140 $0.145 risen by 3.57%
- Litigation involving former employee 8 Jan 2025 10:40AM $0.115 $0.145 risen by 26.09%

26 - 50 of 748 results

Page 2 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.